Clinical Trial Update: FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS) [Phase 2]

View source ↗

Summary

Phase 2 trial FABULINUS evaluating FrexalimAB versus placebo to preserve endogenous insulin secretion in adults and adolescents with Type 1 Diabetes on insulin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Frexalimab (SAR441344)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: RECRUITING